Tango Therapeutics, Inc. , a biotechnology company, discovers and develops drugs for the treatment of cancer.
Tango Therapeutics stock last closed at $17.30, up 0.87% from the previous day, and has increased 830.11% in one year. It has overperformed other stocks in the Biotechnology industry by 8.7 percentage points. Tango Therapeutics stock is currently +1,579.61% from its 52-week low of $1.03, and -1.87% from its 52-week high of $17.63.
As of Mar 13, 2026, there are 142.69M shares of TNGX outstanding. The market capitalization of TNGX is $2.47B. In the last 24 hours, 4.21M TNGX shares were traded.
How to Buy Tango Therapeutics Stock
Wondering how to invest in Tango Therapeutics stock? Here's how.
Decide where to buy Tango Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you figure out where to buy Tango Therapeutics stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit money your investment account: Choose your payment method and add your information.
Research Tango Therapeutics stock: The Tango Therapeutics ticker symbol is TNGX. Is Tango Therapeutics stock a good investment? Should you buy shares of TNGX? How do TNGX's underlying business fundamentals look? Do top analysts think Tango Therapeutics is a good buy? Why has TNGX's stock price moved recently? (Hint: Our stock research tools can help you decide if TNGX is a good stock to buy).
Make your TNGX buy order: Decide if you will purchase TNGX shares at the current market price or use a limit order to buy TNGX stock at a specific price.
Get notifications regarding your TNGX investment: Create a watchlist to important notifications about your new investment in Tango Therapeutics shares.
Step 1: Decide where to buy Tango Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy TNGX stock.
A brokerage account is an investment account that allows you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to global financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal info so you are able to invest in TNGX today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Tango Therapeutics stock
Once you have decided on the best place to buy Tango Therapeutics stock, it's crucial to research their stock before you buy, so you can comprehend the risk and upside.
Tango Therapeutics shares at a glance
TNGX Price
$17.30
1w %
2.06%
1y %
830.11%
5y %
55.72%
P/E
-19.89x
P/B
7.13x
P/S
32.22x
PEG
N/A
Revenue
$62.38M
Earnings
-$101.59M
Fore. Rev. Growth
10.68%
Fore. Earn. Growth
N/A
Market Cap
$2.47B
Next Earnings
Mar 30, 2026
Next Dividend
N/A
TNGX Due Diligence Score
WallStreetZen was designed to help everyday investors do better fundamental analysis in less time.
There are more short-term assets than short-term liabilities on the TNGX balance sheet.
TNGX has cash burn of 139934000. It has enough cash and short-term investments to cover this for at least one year.
TNGX has a low debt to equity ratio of 0.15.
Total TNGX debt is lower than 5 years ago, relative to shareholder equity.
TNGX has $343.57M in cash and short term investments. This is sufficient to cover its annual cash burn of $139.93M.
There are more short-term assets than long-term liabilities on the TNGX balance sheet.
Failed Health Checks:
TNGX profit margin has gone up by 1.47 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy TNGX stock, according to Wall Street analysts?
Out of 8 Equities analysts who give ratings on TNGX, the consensus analyst rating on TNGX is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Latest TNGX Analyst Recommendations
Kelsey Goodwin, a top 9% analyst from Piper Sandler maintains TNGX with a strong buy rating and raises their TNGX price target from $11.00 to $14.00, on Jan 16, 2026.
Piper Sandler's Kelsey Goodwin raised their price target on Tango Therapeutics (NASDAQ: TNGX) by 27.3% from $11 to $14 on 2026/01/16. The analyst maintained their Strong Buy rating on the stock.
Goodwin told readers they updated their 2026 Catalyst Tracker for the sector, as well as several models and price targets, after a flurry of updates from companies in the space.
Yuan Zhi, a top 8% analyst from B. Riley Securities maintains TNGX with a strong buy rating and raises their TNGX price target from $8.00 to $14.00, on Nov 18, 2025.
Charles Zhu, a top 21% analyst from Guggenheim maintains TNGX with a strong buy rating and raises their TNGX price target from $10.00 to $12.00, on Oct 24, 2025.
Last year, TNGX revenue was $62.38M. In the past 5 year, TNGX's revenue has gone up by 52.13% per year. This was faster than the Biotechnology industry average of 29.39%.
No, Tango Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about TNGX?
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your TNGX buy order
You have two main options:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are mostly the best for newer investors.
Limit order: A limit order is an order to buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at an exact price limit, use a limit order.
Click the Open Trade button and your broker will execute your order.
If you want more info about buying stocks on eToro, click the how to video below:
How much does it cost to buy one Tango Therapeutics share?
As of Mar 13, 2026, it costs $17.30 to buy one share of Tango Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $8, you can buy 0.462 shares of TNGX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.